Show simple item record

Streptokinase improves reperfusion blood flow after coronary artery occlusion

dc.contributor.authorMickelson, Judith K.en_US
dc.contributor.authorSimpson, Paul J.en_US
dc.contributor.authorLucchesi, Benedict Roberten_US
dc.contributor.authorGallas, Mennen T.en_US
dc.contributor.authorCronin, Meganen_US
dc.contributor.authorHoff, Paul J.en_US
dc.contributor.authorMcGillem, Mark J.en_US
dc.date.accessioned2006-04-07T20:48:30Z
dc.date.available2006-04-07T20:48:30Z
dc.date.issued1989-06en_US
dc.identifier.citationMickelson, Judith K., Simpson, Paul J., Lucchesi, Benedict R., Gallas, Mennen T., Cronin, Megan, Hoff, Paul J., McGillem, Mark J. (1989/06)."Streptokinase improves reperfusion blood flow after coronary artery occlusion." International Journal of Cardiology 23(3): 373-384. <http://hdl.handle.net/2027.42/27920>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T16-4C06JDM-15/2/5c0e09718c666a72dac11f13df6f9b61en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/27920
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2737780&dopt=citationen_US
dc.description.abstractStreptokinase is an effective thrombolytic agent which, with early restoration of coronary blood flow, has the potential for limiting infarct size. Distinct from thrombolysis, we studied the effects of streptokinase on reperfusion coronary blood flow and infarct size. Open-chest anesthetized canines underwent a 90 minute snare occlusion of the left circumflex coronary artery followed by release and reperfusion through a critical stenosis for 6 hours. The animals were assigned randomly to two groups. Intracoronary streptokinase [group 1 (n = 8): 6000 IU/kg in 3 ml of saline] or saline [group 2 (n = 8): 3 ml of saline] was infused at 0.05 ml/min for 60 minutes beginning 30 minutes before reperfusion. Coronary blood flow was stable in group 1 during reperfusion, while in group 2 it fell during 6 hours of reperfusion (30 +/- 4 ml/min to 18 +/- 2 ml/min, P = 0.05). The ST-segment elevation on the limb lead II electrocardiogram 15 minutes after coronary artery occlusion was similar in both groups (group 1: 3.9 +/- 0.6 mV, group 2: 2.3 +/- 0.5 mV), suggesting the extent of myocardial ischemia was also similar in both groups. The infarct sizes were similar when expressed both as a percent of the total left ventricular mass [(IZ/LV) group 1: 17 +/- 2.5%, group 2: 17.5 +/- 2.5%] or as a percent of the area at risk of infarction [(IZ/AR) group 1: 39 +/- 6%, group 2: 39 +/- 5%]. In both groups, the mass of left ventricle dependent on the blood flow distribution of the left circumflex coronary artery was similar when compared to total left ventricular mass [(AR/LV) group 1: 41 +/- 3%, group 2: 44 +/- 4%]. These results demonstrate that streptokinase maintains reperfusion coronary blood flow through a critical stenosis at a rate similar to baseline levels. Despite the fact that coronary blood flow remained stable with streptokinase during reperfusion, infarct size was not limited after 90 minutes of fixed coronary artery occlusion in this canine model of myocardial injury.en_US
dc.format.extent1277628 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleStreptokinase improves reperfusion blood flow after coronary artery occlusionen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical School and Veterans Administration, Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationumUniversity of Michigan Medical School and Veterans Administration, Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationumUniversity of Michigan Medical School and Veterans Administration, Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationumUniversity of Michigan Medical School and Veterans Administration, Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationumUniversity of Michigan Medical School and Veterans Administration, Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationumUniversity of Michigan Medical School and Veterans Administration, Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Pharmacology and Internal Medicine (Division of Cardiology), Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.identifier.pmid2737780en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/27920/1/0000344.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0167-5273(89)90198-8en_US
dc.identifier.sourceInternational Journal of Cardiologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.